Meeting Overview - The 20th meeting of the 11th Supervisory Board of Shandong Xinhua Medical Instrument Co., Ltd. was held on August 27, 2025, with all three supervisors present, meeting legal and regulatory requirements [1][2]. Financial Report Review - The Supervisory Board approved the 2025 semi-annual report, affirming that the report accurately reflects the company's operational and financial status, with no false records or omissions [2][3]. - The voting results for the approval were unanimous, with 3 votes in favor and none against or abstaining [2]. Fund Management Report - The Board also approved the special report on the management and use of raised funds for the first half of 2025, confirming compliance with relevant regulations and that funds were stored in dedicated accounts and used appropriately [2][3]. - The voting results for this report were also unanimous, with 3 votes in favor [2]. ESG Report Approval - The Supervisory Board approved the 2024 Environmental, Social, and Governance (ESG) report, stating that the preparation and review processes met legal and regulatory standards, and the report accurately reflects the company's situation [3]. - The voting results for the ESG report were unanimous, with 3 votes in favor [3].
新华医疗: 新华医疗第十一届监事会第二十次会议决议公告